BRIEF-Rani Therapeutics Announces Up To $1.085 Billion Collaboration With Chugai Pharmaceutical Co. For Multiple High-Value Therapeutics Including Rare Disease And Immunology Programs And Announces Concurrent Oversubscribed $60.3 Million Financing
Reuters
Yesterday
BRIEF-Rani <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Up To $1.085 Billion Collaboration With Chugai Pharmaceutical Co. For Multiple High-Value Therapeutics Including Rare Disease And Immunology Programs And Announces Concurrent Oversubscribed $60.3 Million Financing
RANI THERAPEUTICS ANNOUNCES UP TO $1.085 BILLION COLLABORATION WITH CHUGAI PHARMACEUTICAL CO. FOR MULTIPLE HIGH-VALUE THERAPEUTICS INCLUDING RARE DISEASE AND IMMUNOLOGY PROGRAMS AND ANNOUNCES CONCURRENT OVERSUBSCRIBED $60.3 MILLION FINANCING
RANI THERAPEUTICS HOLDINGS INC - TO RECEIVE $10 MILLION UPFRONT AND UP TO $75 MILLION IN MILESTONES
RANI THERAPEUTICS HOLDINGS : CHUGAI HAS OPTION TO EXTEND RIGHTS TO PARTNER WITH CO ON UP TO 5 ADDITIONAL DRUG TARGETS
Source text: ID:nGNXbqCxYy
Further company coverage: RANI.O
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.